Marsha Fanucci's Net Worth
$12.3 Million
Who is Marsha Fanucci?
Marsha Fanucci has an estimated net worth of $12.3 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., Forma Therapeutics Holdings, Inc.,, IRONWOOD PHARMACEUTICALS INC, Syros Pharmaceuticals, Inc., Cyclerion Therapeutics, Inc., MOMENTA PHARMACEUTICALS INC, and MILLENNIUM PHARMACEUTICALS INC.
SEC CIK
Marsha Fanucci's CIK is 0001298814
Past Insider Trading and Trends
2019 was Marsha Fanucci's most active year for acquiring shares with 11 total transactions. Marsha Fanucci's most active month to acquire stocks was the month of May. 2008 was Marsha Fanucci's most active year for disposing of shares, totalling 29 transactions. Marsha Fanucci's most active month to dispose stocks was the month of April. 2019 saw Marsha Fanucci paying a total of $1,035,000.00 for 138,900 shares, this is the most they've acquired in one year. In 2019 Marsha Fanucci cashed out on 154,056 shares for a total of $7,500,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $246.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
∞
| 136 |
—
|
—
| 136 |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
$56.90 | -$6,465,000.00 |
0
|
Scheduled
|
Nov 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| -100.00% | -10.00K |
$105.80 | -$1,057,952.83 |
0
|
Scheduled
|
Feb 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
∞
| 10K |
$10.75 | $107,500.00 | 10K |
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Forma Therapeutics Holdings, Inc., No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -59.78K |
—
|
—
|
0
|
Oct 14
| |||
Form 4
| +8.14% | 4.5K |
—
|
—
| 59.78K |
Jun 8
| |||
Form 4
| +5.23% | 2.75K |
—
|
—
| 55.28K |
Jun 17
| |||
Form 4
| -22.63% | -15.36K |
—
|
—
| 52.53K |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IRONWOOD PHARMACEUTICALS INC (IRWD) Snapshot price: $4.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.97% | -4.06K |
—
|
—
| 132.66K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
| 136.72K |
Dec 31
| |||
Form 4
| +21.45% | 16.22K |
—
|
—
| 91.86K |
May 31
| |||
Form 4
| +26.04% | 15.63K |
—
|
—
| 75.63K |
May 31
| |||
Form 4
| +65.16% | 23.67K |
—
|
—
| 60.01K |
Jun 1
| |||
Form 4
| +83.71% | 16.56K |
—
|
—
| 36.33K |
Jun 3
| |||
Form 4
| -61.31% | -31.34K |
$15.68 | -$491,395.52 | 19.78K |
Scheduled
|
Mar 18
| ||
Form 4
| +63.11% | 19.78K |
—
|
—
| 51.12K |
Jun 3
| |||
Form 4
| +42.45% | 9.34K |
—
|
—
| 31.34K |
Jan 2
| |||
Form 4
|
∞
| 22K |
$11.25 | $247,500.00 | 22K |
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $1.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.33% | 4K |
—
|
—
| 16K |
Jun 5
| |||
Form 4
| +50.00% | 4K |
—
|
—
| 12K |
Jun 1
| |||
Form 4
|
∞
| 8K |
—
|
—
| 8K |
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cyclerion Therapeutics, Inc. (CYCN) Snapshot price: $3.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4/A
|
∞
| 16.95K |
—
|
—
| 16.95K |
Apr 1
| |||
Form 4
|
∞
| 16.95K |
—
|
—
| 16.95K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |